YOLFTbeta
Livzon Pharmaceutical Group Inc

Livzon Pharmaceutical Group Inc

000513 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

31.67CNY+0.14 (+0.44%)

Price History

Full chart

Market Stats

Previous Close31.53
Open31.52
Day Range31.20 – 32.00
52-Week Range25.74 – 37.52
Volume7.33M
Market Cap29.21B
P/E (TTM)17.41
Forward P/E24.27
EPS1.89
Dividend Yield7.45%
Beta0.11
50-Day Avg28.76
200-Day Avg32.13

About

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People's Republic of China and internationally. The company offers leuprorelin acetate microspheres, urofollitropin, and menotropins for injection for the assisted reproduction field; Ilaprazole enteric-coated tablets, ilaprazole sodium for injection, and bismuth potassium citrate products for the gastrointestinal field; fluvoxamine maleate for the psychiatric and neurological field; and shenqi fuzheng injection and anti-viral granules for the traditional Chinese medicine field. It also produces APIs and intermediates, such as mevastatin, acarbose, teicoplanin, gentamycin sulfate, phenylalanine, vancomycin hydrochloride, daptomycin, milbemycin oxime, and ceftriaxone sodium, as well as diagnostic reagents such as diagnostic kits for IgM antibody to mycoplasma pneumonia; diagnostic kits for human immunodeficiency virus antibody; and livzon antinuclear antibody test kits. In addition, the company offers nucleic acid test kits; livzon interferon-gamma release assays test kits; influenza A/B virus antigen detection kits; and treponema pallidum antibody detection kits. Further, it provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, stomatitis granules, biochemical and polypeptide APIs, and antibiotic APIs, as well as diagnostic equipment. Livzon Pharmaceutical Group Inc. was incorporated in 1985 and is headquartered in Zhuhai, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Liu Ning
  • Employees8.88K
  • HeadquartersHeadquarters Building, Zhuhai, China, 519090, China
  • Websitehttps://www.livzon.com.cn

Leadership

  • Ms. Liu NingCompany Secretary & Secretary to the Board · b. 1983
  • Ms. Yuxuan HuangVice President · b. 1968
  • Mr. Jun DuVice President · b. 1978
  • Mr. Xiao XuVice President · b. 1978
  • Mr. Sheng WangFinancial Controller, Head of Accounting Department & CFO · b. 1982
  • Dr. Jianing LiuChief Investment Officer & Head of BD Dept.
  • Mr. Maolin WangGM of Legal & Compliance · b. 1966
  • Mr. Zhihua ChenVice President · b. 1981

Financials

Income Statement

Currency: CNY1991-12-311992-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue695.92M699.72M600.07M682.73M721.13M822.21M888.89M1.13B1.18B1.40B1.60B1.81B1.55B1.63B1.59B1.75B2.06B2.60B2.73B3.16B3.94B4.62B5.54B6.62B7.65B8.53B8.86B9.38B10.52B12.06B12.63B12.43B11.81B11.91B
Growth (%)-+0.55%-14.24%+13.78%+5.62%+14.02%+8.11%+27.55%+3.95%+18.43%+14.72%+13.16%-14.19%+4.59%-2.19%+9.91%+17.76%+26.10%+5.04%+16.00%+24.68%+17.12%+20.04%+19.41%+15.58%+11.49%+3.86%+5.91%+12.10%+14.67%+4.69%-1.58%-4.97%+0.82%
Cost of Revenue578.55M571.84M423.94M466.51M475.57M526.10M573.83M622.82M634.76M741.37M894.47M914.62M791.51M906.23M814.30M973.62M1.12B1.23B1.29B1.40B1.62B1.72B2.19B2.60B2.79B3.11B3.41B3.44B3.74B4.31B4.58B4.77B4.25B4.28B
Gross Profit117.37M127.88M176.13M216.23M245.55M296.11M315.06M511.00M543.79M654.42M706.74M897.29M763.28M719.92M695.75M774.49M942.32M1.36B1.44B1.76B2.33B2.90B3.35B4.02B4.87B5.42B5.45B5.94B6.78B7.75B8.05B7.66B7.56B7.63B
Gross Margin16.87%18.28%29.35%31.67%34.05%36.01%35.44%45.07%46.14%46.89%44.14%49.52%49.09%44.27%43.74%44.30%45.77%52.54%52.82%55.80%59.04%62.74%60.41%60.73%63.58%63.51%61.49%63.32%64.41%64.28%63.76%61.61%64.03%64.07%
Operating Expense57.41M66.80M69.83M142.67M178.02M258.52M306.05M513.39M508.47M546.56M592.29M738.46M640.29M588.18M575.88M479.79M602.14M780.58M923.82M1.34B1.85B2.31B2.76B3.33B3.98B-240.08M4.17B4.21B4.28B5.49B5.70B5.24B4.72B5.01B
Operating Income59.97M61.08M106.30M73.56M67.53M37.59M9.00M-2.38M35.32M107.87M114.45M158.84M122.98M131.74M119.87M294.70M340.18M583.28M516.41M429.74M481.11M590.56M584.51M692.80M881.32M5.66B1.27B1.73B2.50B2.27B2.35B2.42B2.84B2.62B
Operating Margin8.62%8.73%17.72%10.77%9.36%4.57%1.01%-0.21%3.00%7.73%7.15%8.77%7.91%8.10%7.54%16.86%16.52%22.47%18.94%13.59%12.20%12.79%10.54%10.46%11.52%66.32%14.38%18.43%23.77%18.79%18.61%19.43%24.08%22.03%
EBITDA76.10M75.58M90.85M77.01M64.04M49.79M24.26M38.87M97.25M190.71M204.89M251.29M241.91M247.55M341.32M772.82M281.46M741.04M672.30M626.25M633.10M741.63M849.97M1.09B1.29B1.45B1.36B1.76B2.42B2.34B2.56B2.74B3.09B3.18B
EBITDA Margin10.93%10.80%15.14%11.28%8.88%6.06%2.73%3.43%8.25%13.66%12.80%13.87%15.56%15.22%21.46%44.21%13.67%28.55%24.66%19.80%16.05%16.06%15.33%16.45%16.89%17.05%15.40%18.73%23.01%19.42%20.29%22.05%26.12%26.68%
Net Income57.78M59.24M101.11M80.15M81.44M44.47M40.83M1.65M10.38M50.39M61.94M92.20M124.06M107.89M188.14M508.45M52.07M481.58M418.18M359.37M441.67M487.50M515.98M622.64M784.35M4.43B1.08B1.30B1.71B1.78B1.91B1.95B2.06B2.02B
Net Income Margin8.30%8.47%16.85%11.74%11.29%5.41%4.59%0.15%0.88%3.61%3.87%5.09%7.98%6.63%11.83%29.09%2.53%18.55%15.34%11.36%11.20%10.56%9.31%9.40%10.25%51.91%12.21%13.88%16.30%14.72%15.12%15.72%17.45%16.99%
R&D--------------30.50M-----124.04M146.98M290.02M362.45M473.21M564.99M616.19M760.37M884.10M1.15B1.43B1.33B1.03B842.84M
R&D as % of Total Revenue--------------1.92%-----3.15%3.18%5.23%5.47%6.18%6.62%6.95%8.10%8.40%9.50%11.30%10.74%8.75%7.08%
Interest Expense16.13M15.67M915.49K18.75M14.45M18.33M11.92M7.93M10.28M14.11M21.14M10.00M9.05M18.71M33.62M30.39M43.93M18.28M12.19M22.11M22.83M13.56M32.90M35.45M30.57M6.66M19.86M11.01M30.37M87.87M103.06M106.89M93.01M61.74M
Interest Expense % of Total Revenue2.32%2.24%0.15%2.75%2.00%2.23%1.34%0.70%0.87%1.01%1.32%0.55%0.58%1.15%2.11%1.74%2.13%0.70%0.45%0.70%0.58%0.29%0.59%0.54%0.40%0.08%0.22%0.12%0.29%0.73%0.82%0.86%0.79%0.52%

Balance Sheet

Currency: CNY1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-594.26M797.27M870.12M1.11B1.32B1.51B1.44B1.56B1.55B1.67B1.86B2.13B2.20B2.16B2.52B2.95B2.92B3.12B3.66B4.60B5.63B6.57B7.30B8.08B10.53B15.90B17.44B17.98B20.59B22.37B24.87B25.04B24.46B23.99B
Total Liabilities-318.71M250.60M246.65M447.49M547.10M474.51M467.61M583.95M581.24M639.37M727.05M954.70M1.03B925.20M1.08B954.80M1.09B898.92M1.02B1.59B2.45B2.96B3.22B3.27B3.42B4.66B5.69B5.70B6.95B8.06B9.93B10.28B9.55B8.20B
Total Equity-275.56M546.67M618.26M657.10M738.53M993.12M925.31M902.00M876.53M915.89M950.20M1.04B1.14B1.20B1.40B1.94B1.78B2.15B2.52B2.84B3.01B3.34B3.70B4.35B6.51B10.77B10.65B11.17B12.11B13.00B13.88B14.04B13.86B13.89B
Cash-80.11M51.43M50.89M37.11M89.02M76.34M43.31M152.53M110.02M232.80M295.28M424.07M303.47M129.50M283.85M282.66M540.18M588.53M863.93M1.45B1.22B761.04M715.71M798.30M2.06B7.42B8.59B8.86B9.95B9.15B10.41B11.33B10.83B9.31B
Total Debt-227.22M104.84M107.36M198.62M312.88M191.72M219.13M193.16M224.01M252.20M329.12M517.50M537.82M508.29M689.49M449.71M621.41M309.31M274.26M252.52M536.87M1.04B842.42M250.70M324.90M662.96M1.50B1.36B1.92B2.69B3.61B3.48B3.93B3.85B
Net Debt-147.11M53.41M56.48M161.50M223.86M115.38M175.81M40.63M113.99M19.40M33.84M93.43M234.34M378.79M405.64M167.05M81.23M-279.22M-589.68M-1.20B-684.46M279.94M126.71M-547.60M-1.74B-6.75B-7.09B-7.49B-8.03B-6.46B-6.80B-7.84B-6.89B-5.46B

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-18.21M246.23M38.52M155.15M213.65M300.01M181.46M161.07M226.46M248.55M345.18M494.88M633.30M708.20M593.96M439.99M717.39M927.79M1.28B1.32B1.27B1.77B2.16B1.90B2.77B3.25B2.98B3.18B
Investing Cash Flow-15.63M-87.81M-95.73M-115.52M-108.54M-268.04M-164.98M-221.47M-136.17M-14.41M-20.02M13.96M-330.49M-422.27M-895.49M-874.57M-738.01M-558.42M-943.24M4.67B-1.02B-316.02M-467.84M-1.88B-1.23B-708.37M-660.33M-3.77B
Financing Cash Flow2.44M-49.20M14.71M52.50M-42.97M96.96M-137.21M-111.92M64.25M-233.05M-63.37M-490.94M-14.12M304.09M47.21M7.77M-20.88M-314.88M938.76M-583.13M857.42M-1.18B-518.04M-815.02M-720.36M-1.66B-2.49B-2.69B
Capital Expenditure31.74M73.44M61.49M81.48M103.62M103.56M146.48M256.72M180.45M91.28M75.52M131.41M336.95M348.83M762.30M920.00M665.52M477.13M368.46M294.15M474.47M398.00M646.98M1.31B940.15M820.45M570.16M574.14M
Free Cash Flow-49.95M172.78M-22.98M73.66M110.03M196.45M34.98M-95.65M46.01M157.28M269.66M363.47M296.34M359.37M-168.34M-480.01M51.87M450.65M910.76M1.02B793.15M1.37B1.51B593.23M1.83B2.43B2.41B2.60B
Dividends Paid22.62M39.19M22.04M26.03M44.24M76.77M42.77M63.83M37.23M33.63M192.57M51.71M55.91M37.09M185.27M192.26M199.28M83.42M231.15M216.26M1.12B868.46M1.07B1.17B1.22B1.49B1.34B982.06M
FCF to OCF274.29%70.17%-59.66%47.48%51.50%65.48%19.28%-59.38%20.32%63.28%78.12%73.45%46.79%50.74%-28.34%-109.10%7.23%48.57%71.20%77.65%62.57%77.48%70.06%31.18%66.09%74.75%80.86%81.94%
Dividend Paid to FCF-45.29%22.68%-95.93%35.33%40.21%39.08%122.27%-66.73%80.92%21.38%71.41%14.23%18.87%10.32%-110.06%-40.05%384.16%18.51%25.38%21.17%141.30%63.43%71.01%196.98%66.32%61.25%55.64%37.70%

Earnings

Report DateMar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Oct 28, 2013Mar 24, 2014Apr 29, 2014Aug 27, 2014Oct 27, 2014Mar 23, 2015Apr 29, 2015Aug 26, 2015Oct 27, 2015Mar 24, 2016Apr 21, 2016Aug 19, 2016Oct 25, 2016Mar 24, 2017Apr 27, 2017Aug 22, 2017Oct 25, 2017Mar 25, 2018Apr 23, 2018Aug 17, 2018Oct 25, 2018Mar 27, 2019Apr 25, 2019Aug 16, 2019Oct 22, 2019Mar 25, 2020Apr 20, 2020Aug 25, 2020Oct 23, 2020Mar 22, 2021Apr 21, 2021Aug 24, 2021Oct 25, 2021Mar 28, 2022Apr 21, 2022Aug 9, 2022Oct 25, 2022Mar 30, 2023Apr 20, 2023Aug 23, 2023Oct 24, 2023Mar 28, 2024Apr 23, 2024Aug 22, 2024Oct 23, 2024Mar 26, 2025Apr 23, 2025Aug 20, 2025Oct 21, 2025Mar 24, 2026Apr 23, 2026Aug 21, 2026
EPS Estimate--------------------------0.16-0.21-0.200.12-0.19-0.15--0.120.150.340.250.260.140.330.280.330.240.370.290.440.130.410.410.410.310.550.590.670.380.660.600.510.400.680.630.610.430.610.550.570.370.700.570.600.370.720.64
EPS Actual0.150.120.250.070.060.01-0.01-0.000.140.150.120.160.150.140.100.110.150.110.070.090.140.130.140.120.170.130.140.130.150.170.120.110.210.170.180.150.260.210.200.210.390.240.230.200.300.310.240.160.330.610.320.280.430.640.440.320.550.590.410.350.590.500.520.430.620.600.500.380.650.620.540.430.710.720.530.310.650.40
Surprise---------------------------12.50%--28.57%--40.00%-8.33%--10.53%-0.00%--66.67%40.00%14.71%-4.00%-11.54%42.86%-9.09%10.71%-27.27%-33.33%-10.81%110.34%-27.27%115.38%4.88%56.10%7.32%3.23%0.00%0.00%-38.81%-7.89%-10.61%-16.67%1.96%7.50%-8.82%-4.76%-18.03%-11.63%6.56%12.73%-5.26%16.22%1.43%26.32%-11.67%-16.22%-9.72%-37.50%
Timing--------------------------After-hours-Pre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap29.21B
Enterprise Value17.51B
Trailing P/E17.41
Forward P/E24.27
PEG Ratio0.00
Price / Sales2.72
Price / Book1.84
EPS1.89
Book Value15.05
Revenue (TTM)10.75B
Gross Profit (TTM)6.82B
EBITDA2.81B
Profit Margin15.58%
Operating Margin18.52%
Return on Equity13.42%
Return on Assets5.93%
Shares Outstanding588.10M
Shares Float460.63M
Beta0.11
Dividend Yield7.45%
Dividend Rate2.45
Payout Ratio75.66%

Dividends

20262×
1.02Oct 14, 20261.43Jun 16, 2026
20251×
1.10Jun 13, 2025
20241×
1.35Jul 8, 2024
20231×
1.60Jul 4, 2023
20221×
1.30May 31, 2022
20211×
1.25Jun 1, 2021
20201×
1.15Jun 4, 2020
20191×
0.92Jul 3, 2019
20181×
1.18Jun 22, 2018
20171×
0.23Jul 7, 2017
20161×
0.23Jun 15, 2016
20151×
0.04Aug 14, 2015
20141×
0.18Jul 25, 2014
20131×
0.18Jul 18, 2013
20121×
0.18Jun 8, 2012
20111×
0.04May 26, 2011
20101×
0.05May 24, 2010
20091×
0.04Jun 30, 2009
20081×
0.18May 16, 2008
20051×
0.05Aug 3, 2005
20041×
0.03Apr 27, 2004
20031×
0.03Jun 26, 2003
20021×
0.01Jul 30, 2002

Stock Splits

  • Jul 3, 20191.3:1
  • Jun 22, 20181.3:1
  • Jul 7, 201713:10
  • Aug 14, 201513:10
  • Dec 11, 200611:10
  • Sep 4, 19971.243:1
  • May 26, 19941.3:1